Filing Details
- Accession Number:
- 0001209191-18-013348
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-26 16:22:59
- Reporting Period:
- 2018-02-22
- Accepted Time:
- 2018-02-26 16:22:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1631650 | Aimmune Therapeutics Inc. | AIMT | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1253886 | G Patrick Enright | C/O Longitude Capital Partners, Llc 2740 Sand Hill Road, 2Nd Floor Menlo Park CA 94025 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-02-22 | 15,593 | $32.00 | 22,869 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 6,013,134 | Indirect | By LVP2 |
Footnotes
- The shares were purchased in the Issuer's underwritten public offering closed on February 26, 2018.
- Reflects shares held by Longitude Venture Partners II, L.P. ("LVP2"). Longitude Capital Partners II, LLC ("LCP2") is the general partner of LVP2 and may be deemed to share voting and investment power over the shares of the Issuer held by LVP2. The reporting person is a managing member of LCP2 and may be deemed to share voting and investment power over the shares of the Issuer held by LVP2. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
Billionaire Hedge Funds
